Skip to main content

JANE STREET GROUP, LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1595888 NEW YORK, NY

Position in VRDN

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,189,540
-$7,511,829 QoQ
Shares Held
60,815
-78.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Derivatives in VRDN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$2,955,516
PutShares
151,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. VRDN ranks #111 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,189,540 60,815
2026-03-31 $2,955,516 151,100
2025-12-31 $8,701,369 279,607
2025-09-30 $764,234 35,414
2025-09-30 $302,120 14,000
2025-06-30 $170,556 12,200
2025-06-30 $150,103 10,737
2025-03-31 $212,984 15,800
2025-03-31 $1,013,507 75,186
2024-12-31 $920,580 48,022
2024-12-31 $536,760 28,000
2024-09-30 $1,856,400 81,600
2024-09-30 $338,975 14,900
2024-09-30 $7,988,729 351,153
2024-06-30 $1,471,105 113,075
2024-03-31 $869,930 49,682
2023-12-31 $1,480,342 67,968
2023-09-30 $914,816 59,636
2023-06-30 $4,752,028 199,749
2023-03-31 $1,095,064 43,045
2022-03-31 $1,137,467 61,518